Abstract: The present invention provides a system, including methods, apparatus and kits for stabilizing and compressing bone fractures using a compression plate apparatus for stabilizing bone fragments with compression comprising a plate having at least two bone screw holes adapted to accept at least one bone screw each, the plate additionally having at least one elongate hole through the plate; a rack comprising rack teeth located along at least one linear edge of the elongate hole; a pinion axle assembly comprising a pinion axle having a head portion, a pinion gear having complementary gear teeth for engaging the rack teeth and a lower portion having threads for engaging bone.

Abstract: Butadiene copolymers are brominated using certain quaternary ammonium tribromides as the brominating agent. The bromination process proceeds easily under mild conditions, and produces a brominated product that has excellent thermal stability.

Abstract: The various embodiments of the present invention provide a system, including methods, apparatus and kits for connecting bones and/or bone portions using a multi-part bone connector with one or more rotating joints.

Abstract: Butadiene copolymers are brominated in solution using bromine as the brominating agent. The bromination is conducted in the presence of an excess of an aliphatic alcohol, relative to the amount of bromine that is used. The bromination proceeds rapidly at mild conditions, and is selective in that only aliphatic carbon-carbon double bonds are brominated, and unwanted bromination at tertiary carbon atoms is largely or completely avoided. The resulting brominated polymers are characterized in having very good thermal stability.

Abstract: Phosphorus-sulfur compounds have flame retardant activity in organic polymer systems. The phosphorus-sulfur compounds can be represented by the structure: wherein X is oxygen or sulfur, T is a covalent bond, oxygen, sulfur or nitrogen, provided that at least one of X and T is sulfur, each X? is independently oxygen or sulfur, each m is independently zero or 1 when X? is oxygen and zero, 1 or 2 when X? is sulfur, n is at least 1 and preferably at least 2, each R is independently an unsubstituted or inertly substituted hydrocarbyl group or the R groups together form an unsubstituted or inertly substituted divalent organic group and A is an organic linking group.

Abstract: The various embodiments of the present invention provide a system, including methods, apparatus and kits for connecting bones and/or bone portions using a multi-part bone connector with one or more rotating joints.

Abstract: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.

Abstract: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.

Abstract: Embodiments of the invention are directed to a distal interphalangeal (“DIP”) fusion device for connecting a first bone of a patient to a second, adjacent bone of the patient. The device may include an anchor assembly and a compressor assembly. In another embodiment, a separate compressor base assembly is included. In yet another embodiment an access port assembly is included. The anchor assembly is rotationally coupled to one end of the compressor assembly, such that the compressor assembly may rotate about the anchor assembly within a semi-spherical zone (three degrees of rotational freedom) and translate axially (one degree of translational freedom). In an operative position, the anchor assembly is anchored in an intermediate phalanx of a digit of a patient, the compressor assembly is contained in a distal phalanx of the digit, and the distal phalanx is flexed relative to the intermediate phalanx to create a joint angle.

Abstract: Phosphorus-sulfur compounds have flame retardant activity in organic polymer systems. The phosphorus-sulfur compounds can be represented by the structure: wherein X is oxygen or sulfur, T is a covalent bond, oxygen, sulfur or nitrogen, provided that at least one of X and T is sulfur, each X? is independently oxygen or sulfur, each m is independently zero or 1 when X? is oxygen and zero, 1 or 2 when X? is sulfur, n is at least 1 and preferably at least 2, each R is independently an unsubstituted or inertly substituted hydrocarbyl group or the R groups together form an unsubstituted or inertly substituted divalent organic group and A is an organic linking group.

Abstract: Brominated and epoxidized organic compounds are useful flame retardants for polymers such as polystyrene. The organic compounds contain both bromine and oxirane groups, and have molecular weights of at least 1500. The brominated and epoxidized organic compounds can be prepared by sequentially brominating and epoxiding (in either order) a starting compound that contains multiple non-conjugated carbon-carbon double bonds.

Abstract: Certain brominated polymers compounds are effective FR additives for combustible organic polymers. These FR additives include: i) a copolymer having styrene and 2,3-dibromopropylmaleimide repeating units; ii) a brominated polyester having aliphatically bound bromine; iii) an allyl ether of a ring-brominated novolac resin; iv) a 3-bromo-2-hydroxypropyl ether of a novolac resin; v) a 2,3-dibromopropyl ether of a cresol novolac resin; and vi) a brominated ROMP polymer or copolymer.

Abstract: The present invention provides compounds of Formula I: wherein: R1 is a label (e.g., a detectable groups; an anti-tumor agent)s; L is present or absent and when present is a linking group; and x represents an integer from 1 to 10; or a pharmaceutically acceptable salt thereof. the compounds are useful for, among other things, identifying cysteine sulfenic acids in proteins and monitoring oxidative damage in proteins and cells.

Abstract: A thermally stable brominated butadiene copolymer, such as brominated styrene/butadiene block copolymer, brominated random styrene/butadiene copolymer or brominated styrene/butadiene graft copolymer, preparation of the brominated butadiene copolymers, use of the brominated butadiene copolymers as a flame retardant additive and polymeric compositions, both foamed and non-foamed, that incorporate a flame-retarding amount of brominated butadiene copolymer.

Abstract: The present invention relates to flame resistance additives for organic polymers, and in particular polyphosphonate-type flame resistance additives in a polycarbonate or a polyester carbonate and/or in blends of polycarbonate or a polyester carbonate with an acrylonitrile, butadiene, and styrene terpolymer. The aromatic polyphosphonate compounds of the present invention are represented by the structure, wherein a and b are each from 0 to 6, with a+b being from 2 to 6, each R is independently hydrogen, unsubstituted or inertly substituted alkyl having up to 6 carbon atoms, —NO2, —NR12, —C?N, —OR1, —C(O)OR1, or —C(O)NR12 (wherein R1 is hydrocarbyl or hydrogen), each R2 is independently hydrogen, alkyl or inertly substituted alkyl, each R3 is a covalent bond or a divalent linking group, and each R4 is independently an alkyl, aryl, inertly substituted alkyl or inertly substituted aryl group.

Abstract: The present invention provides compounds of Formula I: wherein: R1 is a label (e.g., a detectable groups; an anti-tumor agent)s; L is present or absent and when present is a linking group; and x represents an integer from 1 to 10; or a pharmaceutically acceptable salt thereof. the compounds are useful for, among other things, identifying cysteine sulfenic acids in proteins and monitoring oxidative damage in proteins and cells.

Abstract: Provided herein are methods of treating hemolysis by administering an active compound in an amount sufficient to treat said hemolysis. It has been found that nitroxyl donors or similar compounds preferentially react with cell-free OxyHb, as compared to OxyHb encapsulated in a red blood cell, and reacts with MetHb to form iron-nitrosyl Hb or nitrite bound MetHb. It has also been found that such compounds reduce cell-free Hb and hemolysis. Active compounds are also contemplated for use in combination therapies, for example, in combination with the administration of red blood cells and/or an agent that promotes hematopoiesis, or in combination with the administration of a nitric oxide donor.

Abstract: A method of treating cancer in a subject in need thereof comprises administering said subject reserpine, yohimbine, an analog thereof, or a pharmaceutically acceptable salt or prodrug thereof, in an amount effective to treat the cancer. Compounds and compositions useful for carrying out the method are also described.

Abstract: Active compounds of Formula I are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.

Abstract: Active compounds of Formula (I) are described: wherein: R1 and R2 are each independently C1-C4 alkyl; or R1 and R2 together form a C2-C7 alkylene chain; and Z is a non-steroidal anti-inflammatory drug (NSAID); along with pharmaceutically acceptable salts and prodrug thereof, and methods of using the same.